SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007337
Filing Date
2023-03-10
Accepted
2023-03-10 16:57:42
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20230310.htm   iXBRL 8-K 48228
  Complete submission text file 0000950170-23-007337.txt   163557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20230310_pre.xml EX-101.PRE 9828
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20230310_lab.xml EX-101.LAB 13326
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20230310.xsd EX-101.SCH 2469
6 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20230310_htm.xml XML 4697
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 23724486
SIC: 2834 Pharmaceutical Preparations